Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
QUEEN’S CANCER RESEARCH INSTITUTE In 2003, three internationally recognized groups of cancer researchers at Queen’s University were brought together under one roof in the newly created Queen’s Cancer Research Institute (QCRI). The QCRI is comprised of 3 divisions: Cancer Clinical Trials (NCIC Clinical Trials Group) Cancer Care and Epidemiology (Health services research) Cancer Biology and Genetics (Basic science laboratories) There are a variety of clinical research fellowship opportunities at QCRI. All divisions have a strong track record of successful research fellowships undertaken by clinicians from a variety of disciplines including medical oncology, hematology, and radiation oncology. Many trainees have simultaneously pursued graduate degrees through the Department of Community Health & Epidemiology and School of Policy Studies during their fellowship. Individuals interested in pursuing advanced research training in the following disciplines are encourage to contact members of the Queen’s Cancer Research Institute to discuss fellowship options. NCIC CTG Phase III clinical trials Clinical trial methodology Drug development Cancer Care and Epidemiology Health services/outcomes research Health policy and economics Patient-focused outcomes Cancer Biology and Genetics Drug resistance/metabolism Tumor progression Cell growth/proliferation A variety of funding sources are available to support clinical research fellows. For additional information please see http://qcri.queensu.ca or contact one of the division directors. Roger G. Deeley ([email protected]) Director, Queen’s Cancer Research Institute Division of Cancer Biology and Genetics William J. MacKillop ([email protected]) Head, Department of Community Health and Epidemiology Division of Cancer Care and Epidemiology Ralph M. Meyer ([email protected]) Director, National Cancer Institute of Canada Clinical Trials Group Division of Cancer Clinical Trials See http://www.ctg.queensu.ca/